| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | AXGN Axogen, Inc. | Began Marc A | EVP &General Counsel | Sell | 13,222 | $30.00 | $396,660.00 | -42.0% | +7.7% | - | |
| Dec 11, 2025 | INCY Incyte Corp | Mayes Patrick A | EVP &Chief Scientific Officer | Sell | 5,808 | $95.55 | $554,965.44 | -4.6% | -1.5% | - | |
| Dec 11, 2025 | LUCY Innovative Eyewear Inc | Galkin Vladimir68 | 10% Owner | Buy | 58,723 | $1.50 | $88,255.34 | +3.2% | -29.6% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya81 | Chief Executive Officer | Sell | 4,155 | $3.31 | $13,753.05 | -0.5% | -46.8% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul81 | Chief Data Officer | Sell | 1,213 | $3.31 | $4,015.03 | -0.7% | -46.8% | - | |
| Dec 10, 2025 | ATEC Alphatec Holdings, Inc. | Hunsaker Craig E59 | EVP, People &Culture | Sell | 32,584 | $20.84 | $679,050.56 | -2.5% | -40.1% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Boniface John J.56 | Chief Scientific Officer | Sell | 1,332 | $3.31 | $4,408.92 | -0.9% | -46.8% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 873 | $3.31 | $2,889.63 | -0.3% | -46.8% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Jackson Benjamin83 | General Counsel | Sell | 892 | $3.31 | $2,952.52 | -0.7% | -46.8% | - | |
| Dec 10, 2025 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 104 | $559.90 | $58,229.60 | -100% | -12.6% | - | |
| Dec 10, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner76 | Chief Information Officer | Sell | 616 | $3.31 | $2,038.96 | -0.7% | -46.8% | - | |
| Dec 10, 2025 | AXGN Axogen, Inc. | Dale Michael D64 | Chief Executive Officer | Sell | 25,000 | $30.00 | $750,000.00 | -28.2% | +2.3% | - | |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 11,340 | $83.83 | $950,581.17 | -18.4% | +2.2% | - | |
| Dec 10, 2025 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 21,106 | $20.79 | $438,793.74 | -4.6% | -40.1% | - | |
| Dec 10, 2025 | UFPT Ufp Technologies Inc | Holt Jason | Vice President | Sell | 100 | $213.58 | $21,358.00 | -1.3% | +0.7% | - | |
| Dec 10, 2025 | QDEL Quidelortho Corp | Rhoads Ann D47 | Director | Buy | 750 | $28.28 | $21,206.25 | +5.3% | -32.9% | - | |
| Dec 10, 2025 | SNWV Sanuwave Health, Inc. | Manchester Management Co LLC | Director By Deputization | Sell | 144,810 | $30.73 | $4,450,061.36 | -5.2% | -24.8% | - | |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | Zovighian Bernard J58 | CEO | Sell | 25,350 | $84.95 | $2,153,373.46 | -21.3% | +2.2% | - | |
| Dec 9, 2025 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,700 | $84.47 | $650,412.07 | -16.2% | +1.2% | - | |
| Dec 9, 2025 | DXR Daxor Corp | Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | 18,000 | $0.00 | - | +50.1% | -9.6% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Dale Michael D64 | Chief Executive Officer | Sell | 61,463 | $31.21 | $1,918,137.30 | -41.0% | -4.3% | - | |
| Dec 9, 2025 | AXGN Axogen, Inc. | Kemp Jens | Chief Marketing Officer | Sell | 8,156 | $31.21 | $254,532.45 | -15.1% | -4.3% | - | |
| Dec 9, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 5,232 | $3.04 | $15,905.28 | -1.9% | -37.1% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy61 | Chief Financial Officer | Sell | 1,033 | $25.13 | $25,959.29 | -0.7% | -19.6% | - | |
| Dec 9, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 519 | $25.13 | $13,042.47 | -0.3% | -19.6% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.